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Abstract Objective: To deter-
mine the incidence, risk factors, and
prognostic implications of serum
creatinine changes following major
vascular surgery. Design: Obser-
vational study. Settings: University
hospital. Patients: Cohort of 599
consecutive patients undergoing
elective abdominal aortic surgery.
Interventions: Review of prospec-
tively collected data from 1993 to
2004. Measurements and results:
The receiver-operator characteristic
(ROC) curve analysis was used to
detect the best threshold for postop-
erative elevation in serum creatinine
(∆ Creat) in relation to major com-
plications. A cut-off value of +0.5
mg/dl was selected to define renal
dysfunction (RD0.5 group, n = 91; no
RD0.5, n = 508) that was associated
with higher mortality (7.7% in RD0.5
group vs 1.4% in no RD0.5 group,
P < 0.05), rate of admission to the
ICU (34% vs 13%, P < 0.05), and
incidence of cardiovascular (9% vs
4%, P < 0.05), respiratory (21% vs
7%, P < 0.05), surgical (24% vs
10%, P < 0.05), and septic compli-
cations (9% vs 3%, P < 0.05). After
multivariate analysis with logistic
regression, renal dysfunction was
independently related to low preop-
erative creatinine clearance [< 40
ml/min; odds ratio (OR) 1.5, 95%
confidence interval (CI) 1.1–3.9],
prolonged renal ischemic time (> 40
min; OR, 3.8, 95% CI, 1.9–7.2),
blood transfusion (> 5 units; OR,
1.9, 95% CI 1.2–6.1), and rhabdomy-
olysis (OR, 3.6, 95% CI 1.7–7.9).
Conclusions: Postoperative RD0.5
(∆ Creat > 0.5 mg/dl) occurs in
15% of vascular patients and carries
a bad prognosis. Preoperative renal
insufficiency and factors related to the
complexity of surgery are the main
predictors of renal dysfunction.
Keywords Abdominal vascular
surgery · Renal failure · Renal
dysfunction
Introduction
Acute changes in renal function are common after cardiac
and major vascular surgery [1]. Depending on its defini-
tion, at least 1–28% of patients develop a transient or per-
manent decline in renal function following elective open
abdominal aortic repair [2, 3, 4, 5, 6, 7]. Acute renal failure
is less frequent (1–5%), except after ruptured aneurysm,
and it exerts a profound impact on mortality (up to 50%)
and medical resource utilization [1, 2, 3, 4, 5, 6, 7, 8,
9, 10].
The mechanisms of perioperative renal dysfunction
(RD) are multifactorial, being related to renal ischemia,
circulatory failure, and nephrotoxic agents as well as
the neuroendocrine and inflammatory stress response to
surgery [11, 12]. Hemorrhagic shock, the need for supra-
renal clamping, atheroma or fat embolism, free radicals,
and vasoconstrictive mediators/drugs may all contribute
to acute tubular necrosis, delayed apoptosis, and, in turn,
to multiple organ dysfunction and death [11, 12, 13].
Although various pharmacological agents (mannitol,
calcium-channel antagonists, dopaminergic agonists, loop
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diuretics, and angiotensin-converting enzyme inhibitors)
have been tested to optimize renal perfusion and tubular
function, none have been shown to provide any clinical
benefit compared with conventional approaches targeting
normovolemia with adequate cardiac output [14, 15].
Currently, the lack of uniform criteria to define RD and
retrospective data collection make the existing literature al-
most unusable to analyze the prognostic implications of
mild-to-moderate renal insufficiency in vascular surgical
patients. Hence, the purposes of this observational study
were to describe the pattern of changes in serum creatinine
(∆ Creat), to define RD with regard to incremental mor-
bidity and to identify the risk factors for RD after elective
major vascular surgery.
Methods
With institutional review board approval, all patients who
underwent “open” surgery for aortic abdominal aneurysm
(AAA) or aortic occlusive disease (AOD) between 1 Jan-
uary 1993 and 31 December 2004 were prospectively en-
tered into a computerized database. Patients with thora-
coabdominal aneurysms (n = 31), suprarenal aortic occlu-
sive disease (n = 19), endovascular procedures (n = 34), ur-
gent/emergent surgery (n = 186), and previous renal failure
(n = 3) were all excluded.
A minimum delay of 72 h was imposed between
angiography and surgery. All patients had a balanced
anesthetic regimen (opiates and inhaled isoflurane) and
were equipped with five-lead ECG, an invasive arterial
line and a central venous catheter. Transesophageal
echocardiography (TEE) or a pulmonary artery catheter
(PAC) was used in patients with pulmonary hypertension
(mean pulmonary artery pressure ≥ 30 mmHg), a left ven-
tricular ejection fraction less than 40% and/or a history of
congestive heart failure (n = 102). The surgeon performed
a midline incision in 545 patients and a retroperitoneal
approach in 72 patients.
Regarding perioperative medical management,
a protocol-driven approach was targeted to provide or-
gan protection by controlling body homeostasis, fluid
balance and oxygen transport parameters. For instance,
prophylactic antibiotics (cefazoline 2 g/8 h) were given
for 48 h and body normothermia was maintained with
a forced-air warming device and by heating intravenous
fluids. Vasoactive drugs (nitroglycerine, ephedrine, and
phenylephrine) were administered to control blood pres-
sure, particularly following aortic clamping/unclamping.
A blood salvage device was routinely used and homol-
ogous red blood cell concentrates were administered to
keep the hemoglobin level ≥ 80–90 g/l. Postoperatively,
all patients were managed for 24 h in the postanesthesia
care unit (PACU) or in the intensive care unit (ICU); beta-
blockers were routinely given to keep the heart rate below
70 beats/min. Non-steroidal anti-inflammatory drugs
were not given within the first 24 h, in hemodynamically
unstable patients, and in those with preoperative renal
insufficiency.
Data collection and outcome assessment
Case information spanning 60 perioperative variables was
entered into a continually updated registry. Demographic
data, comorbid conditions, and current medical treatments
were all prospectively collected at the time of the preoper-
ative consultation and after reviewing medical files. The
surgical approach and the anesthetic management were
described in terms of duration (surgery, anesthesia, aortic
cross-clamping, renal ischemia, postoperative ventilation),
arterial grafting, fluid balance (diuresis, crystalloids,
colloids, and blood products), type of vasoactive drugs,
and time to extubation.
Laboratory data included serial measurements of
blood gases, hemoglobin, creatinine, and the highest
value of troponin I or creatine phosphokinase (CPK)
and its isoenzyme CPK-MB. The difference between
the highest/lowest serum creatinine value measured
within the first 72 h and the baseline preoperative
value (∆ Creat) was calculated for each patient and
expressed in percentage (%) or absolute value (mg/dl).
Serum creatinine concentration was measured using
the Jaffe method on a Hitachi 747 analyzer (Roche,
Basel, Switzerland). Intra- and interseries precisions
were 0.7% and 2.3%, respectively; interassay coefficient
of variation was 1.5% at a concentration of 0.9 mg/dl
serum creatinine. The patient’s baseline glomerular
filtration rate was estimated by the Cockcroft–Gault
formula and adjusted for 1.73 m2 of body surface
area [16].
Patient’s clinical status, ECG, chest X-rays, and
laboratory data were daily examined and, complications
were categorized as being related to surgery, sepsis,
rhabdomyolysis, or the cardiac and respiratory systems
(see Appendix 1). In addition, the Sequential Organ
Failure Assessment (SOFA) score was calculated [17] and
mortality was defined as any death occurring during the
hospital stay or within 30 days following surgery.
Statistical analysis
Data are presented as mean (± standard deviation), me-
dian (range), absolute numbers or percentages. An internal
audit of 80 randomly selected cases was performed to
test the completeness and accuracy of the database. The
receiver-operator characteristic (ROC) curve analysis was
used to detect the best threshold for ∆ Creat (in % or
mg/dl) to predict the occurrence of major complications
(death and/or cardiovascular and respiratory complica-
tions). Differences between the two groups (reference
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group and RD0.5 group) were examined using unpaired
Student’s t-test or Mann–Whitney test for continuous
variables and Fisher’s exact test for proportions. For time-
trends analysis, three consecutive 4-year-periods were
considered, a χ2 test for linear trend analyses (extension
of Mantel) was applied followed by Duncan’s multiple
range test. Potential risk factors for RD were identified by
univariate analysis, and those with a P value less than 0.25
were entered in a forward multivariate logistic regression
model. To avoid multi-colinearity, only one variable in
a set of variables with a correlation coefficient greater
than 0.5 was used in the multivariate analysis. Adjusted
odd ratios (OR) with 95% confidence intervals (CI) were
calculated.
Results
From 1993 to 2004, 615 patients underwent elective infra-
renal aortic surgery and completed data were obtained in
599 cases (n = 235 AOD and n = 364 AAA) with a report-
ing accuracy of 95%. Overall, the 30-day mortality rate
was 2.3% (1.3% in patients with AOD and 3.0% among
those with AAA) and 28% of patients presented at least
one major postoperative complication. The incidence of re-
nal failure requiring hemodialysis was 1.3% (n = 8), in all
cases more than 72 h after the intervention.
Incidence of renal dysfunction and major complications
Within the first 72 h after surgery, serum creatinine con-
centrations decreased, remained stable, or increased by no
more than 0.25 mg/dl in 74% of cases; a minor increase
(0.26–0.5 mg/dl) was observed in 11% of cases; and
moderate-to-large increases in ∆ Creat (> 0.5 mg/dl) oc-
curred in 15% of cases (Fig. 1). The incidence of persistent
elevation of creatinine at hospital discharge and the worst
SOFA score increased along with the severity of RD;
of note, 19.5% of the patients with ∆ Creat > 1.5 mg/dl
required hemodialysis.
Based on the frequency distribution of ∆ Creat and its
relationship with the worst non-renal SOFA score, a cut-off
value of +0.5 mg/dl was selected to identify RD0.5 (refer-
ence group, n = 508; RD0.5 group n = 91). The area under
the ROC curve was significantly better with a cut-off value
of +0.5 mg/dl than with +20% ∆ Creat; this model demon-
strated a good model calibration and discriminatory power
(0.79, 95% CI 0.74–0.84 vs 0.65, 95% CI 0.60–0.70 with
a ∆ Creat cut-off value of 20%). Compared with the ref-
erence group, patients with RD0.5 required more frequent
admission to the ICU and presented higher incidences of
surgical, cardiovascular, respiratory and septic complica-
tions (Table 1). Seven of the 91 patients with RD0.5 died
(7.7% vs 1.4% in the reference group, P < 0.05) and mor-
tality rate further increased in those who experienced an-
other organ dysfunction (n = 49; 12.2% vs 2.4% in isolated
RD, P < 0.05).
Over the 12-year period, there was no change in
the incidence of postoperative RD0.5 (1993–1996: 14%,
1997–2000: 16%, 2001–2004: 15%).
Intraoperative hemodynamic monitoring with
PAC/TEE did not influence either the occurrence of
RD0.5 (18.5% vs 14.5% without PAC/TEE, n.s.) or the
incidence of cardiovascular and respiratory complica-
tions (5.6% vs 3.3% and 8.3% vs 7.1%, respectively;
n.s.).
Fig. 1 a Frequency distribution of postoperative serum creatinine
changes among patients undergoing aortic abdominal surgery. b Pro-
portion of patients with persistent elevation in serum creatinine at
hospital discharge () and those requiring hemodialysis () c Rela-
tionship between postoperative changes in serum creatinine and the
Sequential Organ Failure Assessment (SOFA) score.
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Reference group RD group
N = 508 N = 91
Mortality, n pts (%) 7 (1.4) 8 (8.8)*
Intensive Care Unit, n pts (%)
Primary admission 65 (12.8) 31 (34.1)*
Re-admission 15 (2.9) 6 (6.6)
Duration, days, mean (SD) 2.0 (1.3) 3.1 (2.4)*
Hospital Stay (duration), mean (SD) 12.7 (3.1) 17.8 (9.3)*
Surgical complications, n pts (%)
Re-operation 44 (8.7) 19 (22.1)*
Wound infection 17 (3.3) 3 (3.4)
Cardiovascular complications, n pts (%)
Arrhytmia 13 (2.6) 7 (7.7)*
Myocardial infarction 13 (2.6) 6 (6.6)*
Heart failure 12 (2.4) 8 (8.8)*
Stroke 3 (0.6) 2 (2.2)
Respiratory complications, n pts (%)
Postoperative Ventilation > 12 hrs 4 (0.8) 6 (6.6)*
Atelectasis 27 (5.3) 14 (15.4)*
Bronchopneumonia 19 (3.7) 4 (4.4)
Sepsis, n pts (%) 9 (1.8) 8 (8.8)*
Maximal SOFA score, mean (SD) 1.9 (1.2) 6.1 (2.3)*
* RD, renal dysfunction defined by an increase in serum creatine > 0.5 mg/dl
Table 1 Postoperative outcome
according to presence or absence
of renal dysfunction
Table 2 Preoperative risk factors of postoperative renal dysfunction
Reference group RD group Univariate Analysis Multivariate Analysis
N = 508 N = 91 OR (95% CI) P value OR (95% Cl) P value
Age (yrs), mean (SD) 66 (11) 69 (8)
> 70 yrs, n pts (%) 189 (37) 45 (51) 1.6 (1.04–3.8) 0.031 n.s.
Gender
Male, n pts (%) 430 (84) 80 (91)
BMI (kg/m2), mean (SD) 25 (4) 26 (4)
Smoking, n pts (%)
Current 345 (68) 66 (72)
Ex-smoker 102 (20) 16 (17)
Prior PTCA/CABGS, n pts (%) 66 (13) 20 (22) 1.8 (0.98–3.1) 0.054 n.s.
Co-morbidities, n pts (%)
Hypertension 295 (58) 63 (69) 1.7 (1.1–2.9) 0.028 n.s.
Coronary Artery Disease 36 (183) 40 (44) 2.4 (1.2–3.8) 0.009 n.s.
Heart Failure 36 (7) 16 (17) 2.9 (1.2–5.8) 0.004 n.s.
Hypercholesterolemia 223 (45) 39 (43)
Diabetes mellitus 76 (15) 16 (17)
Arrythmia 46 (9) 9 (10)
Conduction blockade 40 (8) 11 (12) 1.9 (1.1–4.3) 0.021 n.s.
Stroke 15 (3) 6 (5)
COPD 56 (11) 18 (20) 2.1 (1.0–3.4) 0.034 n.s.
Preop medications, n pts (%)
Beta-blockers 202 (20) 34 (37) 2.8 (1.3–4.7) < 0.001 n.s.
Calcium channel blockers 117 (23) 17 (19)
ACE Inhibitors/All Antagonists 152 (30) 38 (42) 2.2 (1.1–4.1) 0.015 n.s.
Nitrates 56 (11) 12 (13)
Diuretics 81 (16) 23 (25) 1.8 (1.1–3.1) 0.027 n.s.
Anti-platelets 142 (28) 23 (25)
Laboratory data
Hemoglobin (g/L), mean (SD) 142 (20) 138 (19)
Ccreat (ml/min/1.73 m2), mean (SD) 77 (20) 61 (21)*
Ccreat < 40 ml/min, n pts (%) 20 (4) 37 (41)* 2.2 (1.2–3.9) 0.006 1.5 (1.1–3.9) 0.028
RD, renal dysfunction; BMI, body mass Index; PTCA, percutaneous coronary angioplasty; CABGS, coronary artery bypass graft surgery;
COPD, Chronic Obstructive Pulmonary disease; ACE, angiotensin-converting enzyme inhibitors; All, angiotensin II; Ccreat, creatinine
clearance
* Independent risk factor of renal dysfunction
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Table 3 Perioperative management and postoperative renal dysfunction
Reference group RD group Univariate Analysis Multivariate Analysis
N = 508 N = 91 OR (95% CI) P value OR (95% Cl) P value
Intraoperative period
AAA/AOD (n) 296/212 68/23 2.1 (1.2–4.8) 0.006 n.s.
Fluids (ml.kg−1.h−1), mean (SD)
Crystalloids 16.5 (4.8) 16.2 (5.1)
Colloids 4.1 (2.2) 4.0 (1.6)
Diuresis (ml.kg−1.h−1) 22 (1.4) 1.6 (1.8) 1.5 (0.9–6.8) 0.092 n.s.
Duration (min), mean (SD)
Surgery 271 (71) 307 (101) 1.6 (1.1–5.2) 0.031 n.s.
Aortic clamping 71 (26) 80 (28) 1.9 (1.1–3.2) 0.019 n.s.
Renal ischemia 6 (8) 24 (15)* 5.2 (3.2–9.6) < 0.001 3.8 (1.9–6.2) < 0.001
Vasoactive drugs
Ephedrine (mg), mean (SD) 13 (12) 21 (13)
Phenylephrine (mcg), mean (SD) 448 (401) 744 (503)
Vasopressors, n pts (%) 10 (50) 19 (17)* 1.5 (1.1–2.7) 0.056 n.s.
Postoperative period (24 h)
Fluids (ml.kg−1.h−1), mean (SD) 2.4 (0.6) 2.3 (0.5)
Diuresis (ml.kg−1.h−1) 1.4 (0.7) 1.1 (0.8)
PaO2/FIO2 at POD1 (mmHg), mean (SD) 315 (49) 306 (51)
Hemoglobin at POD1 (g/L), mean (SD) 111 (16) 115 (18)
Homologous transfusion
Patients, n pts (%) 186 (37) 52 (57)
Erythrocytes concentrates, mean (SD) 2.6 (2.1) 3.7 (3.1)* 2.4 (1.4–5.8) 0.004 1.9 (1.2–6.7) 0.021
Fresh Frozen Plasma, mean (SD) 2.5 (1.0) 3.1 (2.3)
Ventilation > 12 hrs, n pts (%) 4 (0.8) 6 (6.6) 2.5 (1.2–9.1) 0.026 n.s.
Rhabdomyolysis, n pts (%) 14 (2.8) 16 (17.6)* 4.1 (2.8–10.4) < 0.001 3.6 (1.7–6.9) < 0.001
AAA, aortic abdominal aneurysm; AOD, aortic occlusive disease; PaO2/FIO2, oxygenation index; POD1, postoperative day 1; ephedrine
> 20 mg and/or phenylephrine > 600 mcg; * lndependent risk factor of renal dysfunction
Risk factors for renal dysfunction
Patient characteristics and perioperative management
are described in Tables 2 and 3. The development of
RD0.5 was more frequently associated with advanced age
(> 70 years), low creatinine clearance, use of chronic
cardiac medications (beta-blockers, diuretics or ACE
inhibitors/angiotensin II antagonists) and the presence
of hypertension, coronary artery disease, heart failure,
electrical conduction blockade, aortic aneurysm, cere-
brovascular disease and COPD. Among the perioperative
events, rhabdomyolysis, the duration of surgery, aortic
cross-clamping and renal ischemia, as well as the need
for homologous transfusions, vasoactive drugs (ephedrine,
phenylephrine) and postoperative ventilation differed
significantly between patients with and without RD0.5.
Using multivariate regression analysis, the develop-
ment of RD0.5 was found to be related to four independent
risk factors: preoperative renal insufficiency (creatinine
clearance < 40 ml/min), renal ischemic time > 40 min, the
need for transfusion (> 5 units), and rhabdomyolysis. The
relationship between the duration of renal ischemia and
postoperative elevation in serum creatinine is illustrated
in Fig. 2.
Fig. 2 Relationship between the duration of renal ischemia and
changes in serum creatinine level within the first 72 h after vascular
surgery
1813
Discussion
In this 12-year cohort study, postoperative renal dys-
function occurred in 15% of 599 consecutive patients
undergoing aortic reconstructive surgery. Renal dysfunc-
tion was defined by changes in serum creatinine exceeding
0.5 mg/dl (RD0.5) that was associated with a 5 times
greater mortality rate and more frequent episodes of
sepsis, cardiopulmonary dysfunction and surgical com-
plications. Importantly, baseline renal impairment, the
duration of renal ischemia, the need for transfusion and
rhabdomyolysis were all predictive of RD0.5. Although
our results do not provide any pathophysiologic insights,
it is tempting to speculate that RD0.5-associated impair-
ments in volume load excretion, electrolyte regulation, and
platelet function contributed to the increased morbidity
and mortality.
Given its nonlinear relationship with glomerular fil-
tration and its low diagnostic sensitivity, change in serum
creatinine (∆ Creat) largely underestimates the occurrence
of renal functional impairment, particularly in patients
with normal or borderline renal function [18]. Neverthe-
less, monitoring serum creatinine is a practical approach
for assessing short-term alteration in renal function,
reflecting reduced renal creatinine clearance, increased
creatinine formation, or both [16, 19]. Compared with
inuline clearance – the reference method for glomerular
filtration – serum creatinine has been shown to be a valid
indicator of early postischemic renal dysfunction and
a predictor of postoperative complications [20]. In pre-
vious studies, preset levels of relative/absolute increase
in serum creatinine were used as biological criteria for
perioperative RD [2, 3, 4, 5, 6, 7]. Instead of arbitrarily
defining RD, we examined the relationship between
serious adverse events and ∆ Creat within the first 3 post-
operative days and we found that a ∆ Creat of 0.5 mg/dl
was the best criterion to discriminate two populations
of patients with different postoperative outcome. After
cardiac surgery and thoracic aortic aneurysm, similar
cut-off values for ∆ Creat (+20%, +0.5–1 mg/dl) have also
been shown to detect mild-to-moderate renal impairment
that was predictive of increased mortality, prolonged
hospital stay, and poor quality of life [21, 22, 23, 24].
In this single-center study, standardization of peri-
operative interventions probably contributed to lowering
the risk of RD0.5, for instance by avoiding nephrotoxic
agents (e.g., non-steroidal anti-inflammatory drugs, radi-
ological contrast agents, antibiotics) and by stabilization
of the hemodynamic condition [14]. Among preoperative
variables, a low creatinine clearance (< 40 ml/min) was
the only predictor of RD0.5. Consistent with this finding,
Powell and Johnston reported a twofold incidence of renal
dysfunction in patients with preoperative serum creatinine
exceeding 2 mg/dl or when the estimated creatinine
clearance was below 40–45 ml/min [4, 25]. Conceptually,
the ongoing renal pathophysiological processes render
the residual nephrons more vulnerable to subsequent
hypoxemic, ischemic, hypotensive, inflammatory, and/or
nephrotoxic insults leading to further deterioration of the
filtering, concentrating, and reabsorbing capacities of the
kidney [12, 26, 27].
Although advanced age and cardiovascular diseases
(e.g., hypertension, heart failure, coronary artery disease,
conduction blockade) were more prevalent in the RD0.5
group, they were not considered as independent risk
factors of RD. Population based studies suggest that these
clinical markers simply parallel the age-related reduction
in functioning nephron mass and/or reflect the progres-
sion of renal vascular atheromatosis and glomerular
sclerosis [28].
Not surprisingly, the main determinant of postopera-
tive creatinine levels was the duration of renal ischemia.
Suprarenal aortic clamping was deemed necessary in
about 20% of our patients, and atheromatous debris could
be dislodged from the aortic intima with subsequent em-
bolization within the renal vasculature. While the risk for
RD0.5 was low for renal ischemia time shorter than 20 min,
renal clamping time exceeding 40 min was associated
with a 60% occurrence of RD0.5. Consistent with these
observations, a “safe” renal ischemia time between 45 min
and 60 min has been supported by previous experimental
and clinical investigations [3, 8, 29, 30]. In a review of
60 patients following aortic reconstruction, Wahlberg
et al. reported a tenfold risk of postoperative elevation
of creatinine when the suprarenal aortic clamping time
was greater than 50 min [31]. Likewise, Kudo et al.
demonstrated a positive correlation between the duration
of renal ischemia and postoperative creatinine elevation,
45 min clamping time being considered the upper limit of
“tolerable” renal ischemia [8].
Among clinical and biological markers reflecting the
extent of surgical trauma and procedural complexity,
rhabdomyolysis and bleeding, expressed by transfusion
requirement, were identified as the sole independent
predictors of postoperative RD0.5. In a similar surgical
population, Bertrand et al. found a 25% incidence of
acute renal failure in a subset of patients who experienced
rhabdomyolysis (compared with less than 1% in those
without rhabdomyolysis) and there was a close association
between the occurrence of rhabdomyolysis (9%) and
longer clamping time, marked intraoperative bleeding,
and the need for visceral artery reimplantation [32].
Altogether, circulating hypovolemia and the cytotoxic
and vasoconstrictive effects of myoglobin are considered
the triggering factors leading to a reduced glomerular
filtration rate as a result of renal hypoperfusion associated
with acute tubular necrosis and apoptosis [33].
We are mindful of several limitations of this obser-
vational study. First, although more than 60 items were
prospectively collected at one center, the criteria and
potential risk factors of RD were investigated a posteriori,
precluding control of several confounding variables and
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the generalization of the results to other institutions.
Selection bias and length bias were unavoidable; for
instance, the surgeon’s choice to select an “open” or
endovascular approach has changed over this 12-year
period, being determined by the recent availability of
this noninvasive technique, the patient’s comorbidities,
and the morphologic features of the aorta, as well as the
operator’s learning curve. Although our logistic regression
analysis adheres to sample size recommendations for 10 or
more outcome events per risk factor, external validation is
needed that would entail a large multicenter database [34].
Second, analysis of several potential risk factors such
as the presence of cardiac insufficiency, diabetes, or cirrho-
sis, chronic use of beta-blockers, angiotensin-converting
inhibitors, or angiotensin blockers and intraoperative in-
terventions (e.g., renal vein ligation, arterial grafting), was
inconclusive due to incomplete data and the small number
of patients in these categories (type II error, false negative
results) [35].
Third, elevated serum creatinine levels persisted at hos-
pital discharge in 40% of our surgical patients and add-
itional cases of mild-to-moderate renal impairments were
probably undetected given the low diagnostic sensitivity
of ∆ Creat [19, 20]. Hence, follow-up studies using sensi-
tive biological markers of glomerular and tubular injuries
are needed to examine whether perioperative elevation in
creatinine represents a transient functional impairment or
a permanent loss of nephrons evolving towards progressive
renal failure.
In summary, the likelihood of developing postopera-
tive RD after major elective vascular surgery is mainly in-
fluenced by baseline renal functional reserve and by fac-
tors related to the complexity of the vascular intervention
(renal ischemia, rhabdomyolysis and bleeding). These re-
sults highlight the importance of preoperative risk stratifi-
cation, implementation of standardized perioperative pro-
tocols, and involvement of multidisciplinary specialized
teams. Accordingly, reduction in postoperative RD should
better be targeted in high-volume hospitals by sharing best
practices of care between highly trained and experienced
health care providers [36].
Appendix
Definitions of major non-fatal complications
Cardiovascular
1. Myocardial infarct: typical rise and fall of CPK
(> 120 U/l) and CK-MB/CPK ≥ 6% or troponin-I
≥ 1.5 ng/ml with at least one of the following criteria:
ischemic symptoms, development of pathological Q
waves on the ECG, ST segment elevation or depression
(≥ 1 mm) or coronary artery intervention
2. Arrhythmias: supraventricular and ventricular tach-
yarrhythmias on ECG requiring anti-arrhythmic
medications and/ or an electrical cardioversion
3. Congestive heart failure: need for sympathomimetic
support, diuretics, or vasodilators consistent with
clinical, hemodynamic (pulmonary artery pressure
≥ 15 mmHg), and radiological evidence of pulmonary
congestion
Cerebral
Stroke: focal neurological deficit (transient or permanent)
Respiratory
1. Atelectasis: lobar collapse (chest X-rays), need for
CPAP and/or bronchoscopy
2. Bronchopneumonia: temperature > 38°C, hyperleuko-
cytosis (neutrophils), new lung infiltration (chest X-
rays), positive culture (bronchial secretions or alveolar
fluid)
3. Prolonged mechanical ventilation ≥ 24 h
Surgical
1. Re-operation for bleeding
2. Re-operation for ischemia
Sepsis
Systemic inflammatory response syndrome (SIRS) asso-
ciated with an infection (positive culture of blood, urine,
bronchoalveolar lavage fluid or other internal fluid speci-
men):
• Body temperature < 35.6° or > 38.3°C
• Tachycardia (> 90 beats/min)
• Ventilatory frequency > 20 bpm or PaCO2 < 4.3 kPa
• White blood cells > 12 × 109/l or < 4 × 109/l, or 10%
immature neutrophils
Rhabdomyolysis
Creatine phosphokinase (CPK) value > 1700 U/l, corre-
sponding to the mean value +2 SD of maximum CPK value
observed after peripheral vascular surgery in our institu-
tion, in the absence of myocardial infarct (see above).
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